Status:
COMPLETED
Minimum Local Anesthetic Dose for Adductor Canal Block
Lead Sponsor:
University Health Network, Toronto
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the minimum dose of ropivacaine 0.5%, required to produce pain relief without weakening the leg muscles.
Detailed Description
The post-operative period after a Total Knee Arthroplasty (TKA) is known to be especially painful for the first 24 hours. Significant pain can persist up to 3 days in some cases. Successful management...
Eligibility Criteria
Inclusion
- ASA(American Society of Anesthesiologists)physical status classification system I-III
- 18-85 years of age, inclusive
- BMI 18 - 40
- Scheduled for elective total knee replacement under spinal anesthesia or general anesthesia.
Exclusion
- Inability or refusal to provide informed consent
- Any contraindication to regional anesthesia (allergy to local anesthetics, bleeding diathesis, coagulopathy, malignancy or infection at the site of block)
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03427385
Start Date
September 1 2012
End Date
August 5 2014
Last Update
February 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8